Vibe Coding in Medical Devices: Faster Build, Same Burden of Proof
Share:
AI-assisted code generation (a.k.a. “vibe coding”) can turbocharge delivery for medical-device software — but shipping still depends on lifecycle controls, security, traceability, and postmarket duties. This guide shows what vibe coding accelerates, what it doesn’t, and how to close the gaps with concrete regulatory references.
Faster build ≠ fewer obligations. Align AI-assisted coding with medical-device lifecycle and cybersecurity requirements.
Objectives
Define “vibe coding” and safe scaffolding boundaries for MedTech teams.
Separate responsibilities for AI as a code assistant vs AI features in the device.
Map requirements to regs/standards (IEC 62304/81001-5-1, FDA PCCP, EU AI Act, NTIA SBOM).
Provide a pragmatic validation approach (CSA/GAMP 5), plus prompt-logging patterns.
Offer a concise checklist and primary reference links for implementation.
At a glance
Two tracks: AI as dev tool vs AI in the device
Gaps vibe coding doesn’t close (and how to close them)
If AI ships in the product (PCCP, AI Act)
Postmarket surveillance duties
Scaffolding: definition + safe examples
GAMP® 5 for EU/GxP teams
Prompt provenance (how to log)
Quick regulatory & standards references
Two Tracks — Keep Them Separate in Your QMS
1) AI as a developer tool (code assistant). You are still shipping conventional software. Prove process control under IEC 62304 (software lifecycle) and IEC 81001-5-1 (secure health-software lifecycle). Add NIST SSDF (SP 800-218) for secure development practices and SLSA for build provenance.
2) AI in the device (AI/ML features). Treat the model as regulated functionality. In the US, plan a Predetermined Change Control Plan (PCCP) so you can update models post-market. In the EU, the AI Act (Reg. (EU) 2024/1689) stacks on top of MDR/IVDR obligations (risk management, data governance, transparency, human oversight).
What Vibe Coding Doesn’t Do (and How to Close It)
1) Design Controls & Traceability (IEC 62304 + ISO 14971)
Maintain SRS/SDS, architecture, hazard/risk analysis, and a requirements→tests trace matrix.
Classify software safety (A/B/C) and match verification depth to risk.
AI-generated code never replaces formal design inputs/outputs; it must be reviewed and verified like any other code.
Threat-model; run SAST/DAST; use software composition analysis (SCA).
Treat any AI-introduced package as SOUP/dependency with provenance and CVE monitoring.
Adopt NIST SSDF controls and SLSA build attestations for tamper-resistant, provenance-stamped builds.
3) SBOMs: Make Them Reviewer-Friendly (and Machine-Readable)
Provide an SBOM aligned to the NTIA Minimum Elements and deliver it in SPDX or CycloneDX.
Include operational “support” fields your team actually uses: maintainer/contact, update policy, coordinated vulnerability disclosure (CVD) intake, and end-of-support dates.
Submit vulnerability monitoring and patchability plans consistent with FD&C Act §524B and FDA’s latest cybersecurity guidance.
4) Explicit Validation Protocol for AI Code Assistants (Inside Your QMS)
Qualify AI code assistants as production/QMS tools using a risk-based, outcomes-focused approach (GAMP® 5 and FDA’s CSA draft spirit):
Allowed vs. prohibited uses: allow scaffolding and boilerplate; prohibit safety algorithms, medical calculations, and crypto.
Gates: SCA = no high-severity vulns; SAST = no high-severity findings; unit coverage ≥ agreed threshold; property-based tests for algorithmic modules.
Independent reviews: require second-person review for Class B/C code and two-person sign-off on risk controls.
Audit trail: PR checklist with reviewer notes, test reports, and scan results filed to the DHF/Device File.
5) Testing That Matters
Unit + integration + hazard-scenario tests tied to the ISO 14971 risk file.
Usability verification when UI affects safe use (IEC 62366-1).
6) Documentation for Submissions
Demonstrate human control of design and verification of risk controls.
Include your NTIA-aligned machine-readable SBOM, vulnerability handling, and patch plan (per §524B).
Use FDA’s Q-Submission program early for novel approaches.
If AI Is In the Device (SaMD/SiMD with ML)
US — PCCP (final): Define what may change, how you will validate deployable changes, and how you will assess impact so model updates do not require a new submission each time.
EU — AI Act + MDR/IVDR: Treat AI safety components as high-risk systems and meet AI-Act documentation on top of MDR/IVDR technical documentation.
Postmarket Surveillance Duty (Make It Explicit)
Under FD&C Act §524B and FDA’s TPLC cybersecurity posture, your submission and ongoing operations must cover:
Monitoring to identify/address vulnerabilities (including CVD processes).
Timely updates and patches, informed by SBOM-driven CVE watch and threat intelligence.
Lifecycle maintenance aligned with IEC 62304 (treat security fixes as safety work).
What We Mean by “Scaffolding” (Definition + Examples)
Scaffolding is auto-generating repeatable, non-novel code structures that speed construction without replacing engineering judgment.
Project bootstraps: repo layout, lint/format configs, CI skeletons.
Keep out of scope for assistants: safety algorithms, medical-calculation logic, cryptography.
EU/GxP Audiences: Add GAMP® 5 (Second Edition)
Risk-based “critical thinking”: scale documentation and testing by impact on patient safety, product quality, and data integrity.
Tool categorization & supplier assessment: classify AI code assistants as tools; document intended use and constraints; assess supplier practices.
Assurance by evidence: emphasize fit-for-intended-use outcomes over checkbox validation.
Configuration over customization: minimize bespoke code; track deviations with tighter controls.
Prompt Provenance (Log It When Safety Is Touched)
Log prompts/outputs whenever generated code touches risk controls, safety-related modules, or regulated data paths. Keep it modular and linkable to SDLC artifacts.
A) PR Template Block
Feature/Change ID (linked to SRS/URS)
Risk Control IDs (ISO 14971 mapping)
Prompt text + model/version (+ parameters if available)
Disclaimer: This article is provided for informational purposes only and does not constitute legal or regulatory advice. Always consult your regulatory and quality teams.